video corpo

IFU-CW3130M-NP

IFU-CW3130M-NP

IFU-CW3130M-NP

Product catalog summary
Product Overview: The Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit is designed for the qualitative detection of SARS-CoV-2 from human oropharyngeal swabs. It is applicable for suspected COVID-19 cases, aggregated cases, and other patients needing diagnosis or differentiation of SARS-CoV-2 infection.
Specifications: The kit uses a fluorescence quantitative PCR platform to detect the virus by targeting the ORF1ab and N genes. It includes components such as lyophilized reaction powder, positive and negative controls, and dissolvents. The kit is compatible with several PCR instruments like ABI 7500 and Bio-rad CFX 96.
Storage and Validity: The kit can be stored at room temperature for up to one month after opening, with a total shelf life of 12 months when stored at 2-8°C.
Procedures: The detection process involves sample collection, reagent preparation, sample addition, and PCR amplification. Samples can include saliva, sputum, and various swabs. The reaction involves reverse transcription, pre-denaturation, denaturation, and annealing/extension phases.
Limitations: Test results are for clinical reference only and not definitive for diagnosis. Negative results may arise from improper sample handling or degradation. The test is limited to specified sample types and instruments.
Performance: The kit shows a 100% compliance rate with positive and negative standard products and a minimum detection limit of 200 copies/ml with a positive detection rate of ≥95%.
Precautions: The kit is for in vitro diagnostic use, requiring trained personnel. Laboratory management must adhere to PCR gene amplification standards, and sample processing should occur in a biosafety cabinet to prevent contamination.
Result Interpretation: Results are interpreted based on CT values, with specific guidelines for positive, negative, and invalid samples. Retesting is recommended for ambiguous results.
See more

Catalog excerpts

IFU-CW3130M-NP-1

Phone : 86-523-86201352 Fax : 86-523-86816890 Email: [email protected] Manufacturer Jiangsu CoWin Biotech Co., Ltd Add: No.58 G52 Building, East of Lujia Road, West Side of Tai Road, China medical city, Taizhou, Jiangsu, 225300 Phone: 86-523-86201352 Fax: 86-523-86816890 Web: https://www.cwbio.com E-mail: [email protected] EC-Representative SUNGO Europe B.V. VAT: NL857821659B01 Add: Olympisch Stadion 24, 1076DE Amsterdam, Netherlands Contact: SUNGO Secretary Tel /Fax: +31 (0) 2021 11106 E-mail: [email protected] Version: A/6 Effective Date: 2021-06-10 Product: Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing) Size: 48 tests/Box/96 tests/Box Applications The Novel Coronavirus (SARS-CoV-2) FAST Nucleic Acid Detection Kit is developed for qualitative detection of SARS-CoV-2 that is collected from human oropharyngeal swabs in vitro. The applicable population includes: suspected cases of Novel Coronavirus (SARS-CoV-2) infected pneumonia, suspected aggregated cases, and other patients who need to be diagnosed or differentiated with Novel Coronavirus (SARS-CoV-2) infection. The novel coronaviruses belong to the p genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. The novel coronavirus detection should meet the requirements of "new laboratory technology related to new coronavirus pneumonia detection guidelines" and address biosafety issues. -1- www.cwbio.com CoWin Biotech CoWin Biotech

 Open the catalog to page 1
IFU-CW3130M-NP-2

4. The sample should be completely added into the reaction solution. After adding the Highly conserved region containing ORF1ab and N gene in the novel coronavirus sample, cover the tube lid as soon as possible and spin the tube. (SARS-CoV-2) genome is used to design specific primers and probes in this kit. Based 5. After amplification, take out the reaction tubes, seal them in a special plastic bag, on the fluorescence quantitative PCR platform, the principle of one-step fluorescence and discard it in a designated place. quantitative reverse transcription PCR was used to qualitatively detect...

 Open the catalog to page 2
IFU-CW3130M-NP-3

Instrument Compatibility Limitations of Test Methods 1. The test results are only for clinical reference and shall not be the only standard for ABI 7500,Bio-rad CFX 96, Tianlong Gentier 96, Lepgen 96, MA-6000. Sample Requirements 2. The negative results can be caused by improper storage conditions of samples, Saliva, sputum, tracheal, aspirate or bronchoalveolar lavage, nasopharyngeal aspirate, nasopharyngeal and pharyngeal swabs, blood urine and stool. inhibitions in the samples and degradation of nucleic acids. 3. Inappropriate sample collection, transfer and treatment, improper experimental...

 Open the catalog to page 3
IFU-CW3130M-NP-4

Positive control and negative control

 Open the catalog to page 4
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.